US Stock MarketDetailed Quotes
HEPA Hepion Pharmaceuticals
- 1.3100
- 0.00000.00%
Close May 9 16:00 ET
7.17MMarket Cap-106P/E (TTM)
1.4000High1.3000Low15.06KVolume1.3080Open1.3100Pre Close20.42KTurnover0.30%Turnover RatioLossP/E (Static)5.47MShares20.660052wk High1.28P/B6.54MFloat Cap1.220052wk Low--Dividend TTM4.99MShs Float8792.0000Historical High--Div YieldTTM7.63%Amplitude1.2200Historical Low1.3550Avg Price1Lot Size
About Hepion Pharmaceuticals Company
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.
Company Profile
SymbolHEPA
Company NameHepion Pharmaceuticals
Listing DateFeb 27, 2015
Founded2013
CEOMr. John T. Cavan
MarketNASDAQ
Employees22
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address399 Thornall Street,1st Floor
CityEdison
ProvinceNew Jersey
CountryUnited States of America
Zip Code08837
Phone1-732-902-4000
Websitehttp://www.hepionpharma.com
Company Executives
- Name
- Position
- Salary
- John T. Cavan
- Interim Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer
- 495.33K
- John Patrick Brancaccio
- Chairman of the Board
- 86.00K
- Michael Purcell
- Director
- --
- Dr. Timothy Block
- Independent Director
- 77.90K
- Dr. Kaouthar Lbiati, M.D.
- Independent Director
- 30.92K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg